RLMD
Relmada Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD6.33
-0.09 (-1.40%)
Rating:C-
Company Profile
CEO
Sergio Traversa
IPO Date
2014-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$6.40
Prev. Close
$6.42
Day Low
$6.25
Day High
$6.49
52W Low
$0.52
52W High
$8.00
Market Cap
$0.46B
Volume
0.79M